Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-08 KOZARICH JOHN W Director Sale −5,819 $76.51 $445K 42,802
2023-05-08 KOZARICH JOHN W Director Sale −589 $77.10 $45K 42,213
2023-05-08 KOZARICH JOHN W Director Option exercise · Non-Qualified Stock Option (right to buy) −6,408 0
2023-03-24 Reardon Andrew See Remarks Sale −300 $69.92 $21K 16,308
2023-02-23 Espinoza Octavio Chief Financial Officer Grant or award +6,046 24,142
2023-02-23 Espinoza Octavio Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +16,419 16,419
2023-02-23 Korenberg Matthew E President & COO Grant or award +9,069 98,748
2023-02-23 Korenberg Matthew E President & COO Grant or award · Employee Stock Option (right to buy) +24,628 24,628
2023-02-23 Reardon Andrew See Remarks Grant or award +5,668 16,608
2023-02-23 Reardon Andrew See Remarks Grant or award · Employee Stock Option (right to buy) +15,393 15,393
2023-02-23 Davis Todd C Chief Executive Officer Grant or award +17,005 68,791
2023-02-23 Davis Todd C Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +46,178 46,178
2023-02-15 Korenberg Matthew E President & COO Shares withheld for taxes −2,890 $72.98 $211K 89,679
2023-02-15 Espinoza Octavio Chief Financial Officer Shares withheld for taxes −849 $72.98 $62K 18,096
2022-12-30 Espinoza Octavio Chief Financial Officer Other acquisition +275 $56.78 $16K 18,945
2022-12-28 Korenberg Matthew E President & COO Shares withheld for taxes −3,859 $66.29 $256K 92,569
2022-12-28 HIGGINS JOHN L Director Shares withheld for taxes −5,289 $66.29 $351K 417,695
2022-12-22 HIGGINS JOHN L Director Grant or award · Non-Qualified Stock Option (right to buy) +92,932 92,932
2022-12-22 Korenberg Matthew E President & COO Grant or award · Employee Stock Option (right to buy) +25,967 25,967
2022-12-22 KOZARICH JOHN W Director Grant or award · Non-Qualified Stock Option (right to buy) +6,623 6,623

Page 26 of 43 · 858 trades